Award of zymeron's DHA sbir phase II medical r & d contract for "development for a novel countermeasure, radiodefender, as a radioprotector for hematopoietic acute radiation syndrome"
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH22C0012
- Awardee
-
Zymeron Corporation UEI GAMMMRQ6QMN1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,999,993
Award facts
- Opportunity
-
- HQ003421R1BDB Solicitation number
- Contract value 100% obligated
- $2,999,992.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,999,993 |
About this award
This is a Small Business Innovation Research (SBIR) Phase II award from the U.S. Army Medical Command (MEDCOM) to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The $2,999,992.85 Firm Fixed Price contract is for the "Development for a Novel Countermeasure, RadioDefender, as a Radioprotector for Hematopoietic Acute Radiation Syndrome". This contract is focused on delivering an innovative medical research and development solution to address the critical healthcare challenge of radiation exposure treatment. Zymeron has demonstrated extensive expertise in securing federal contracts and grants for advanced medical technologies across various agencies, including the Department of Defense and Department of Health and Human Services.
Quick answers
Who was awarded contract W81XWH22C0012?
W81XWH22C0012 was awarded to Zymeron Corporation by Defense Health Agency (Department of Defense) on February 7, 2022.
How much is contract W81XWH22C0012 worth?
The government has obligated $2,999,993 on W81XWH22C0012.
Which agency awarded contract W81XWH22C0012?
Defense Health Agency (Department of Defense) awarded W81XWH22C0012, with funding from Medical Command (Department of the Army).
Was contract W81XWH22C0012 competed?
The extent of competition for W81XWH22C0012 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award